Houston jumps significantly on annual list of best places to live in 2024

by the numbers

H-Town jumped 43 spots into No. 97 this year. Photo via Getty Images

Things are looking a little brighter for Houston as the city was recently named among the top 100 best places to live in U.S. News and World Report's "Best Places to Live" list for 2024-2025.

Previously, H-Town had shockingly plummeted toward the bottom of the list as No. 140 in the 2023-2024 rankings. But the latest report has placed Houston at No. 97, suggesting substantial improvements over the last year.

U.S. News annually measures 150 top American cities for their livability and ranks them based on four major indexes: quality of life, value, desirability, and job market.

New for the 2024-2025 report, U.S. News updated its methodology to analyze city-based data rather than metropolitan area data. Secondly, the report's annual survey decided to place greater weight on a city's "value and job market" while "weights for desirability and quality of life took a slight dip" on the grading scale.

"Rising concerns about career prospects, housing affordability and increased cost of goods and services are reflected in this year’s rankings," said U.S. News loans expert and reporter Erika Giovanetti in a press release. "While quality of life remains the top priority for many Americans, a city’s value and job market are becoming increasingly important for those looking for a place to live."

There's many factors that draw folks to Houston, among them our city's diversity, the highly esteemed schools, top universities, and much more. Houston is also a great place for retirees looking to settle down without compromising on the big city lifestyle. The city truly has something for everyone.

The good news continues: Houston additionally moved up two spots to take No. 8 on the report's Best Place to Live in Texas list for 2024. The Bayou City ranked No. 10 last year.

Elsewhere in Texas
The recent focus on city-based data was likely a major factor that fueled Houston's improvement in the statewide and national rankings, but it also favorably shifted nine other Texas cities.

Austin – which previously ranked No. 40 in last year's rankings – became the only city to represent the Lone Star State among the top 10 best places to live in 2024. The Texas Capital jumped up 31 spots to claim No. 9 nationally, due to its "high desirability and job market scores," the report said.

Three cities in the Rio Grande Valley also ranked higher than Houston, suggesting that South Texas may be a better place to live than East Texas. The border towns of McAllen (No. 48) and Brownsville (No. 87) climbed into the overall top 100 this year after formerly ranking No. 137 and No. 134 last year. Meanwhile, Corpus Christi moved up from No. 132 last year to No. 77 in 2024.

Naples, Florida won the gold medal as the No. 1 best place to live in the U.S. in 2024. Rounding out the top five are Boise, Idaho (No. 2); Colorado Springs, Colorado (No. 3); Greenville, South Carolina (No. 4); and Charlotte, North Carolina (No. 5).

Here's how other Texas cities faired in 2024's Best Places to Live report:

  • No. 62 – El Paso (up from No. 128 last year)
  • No. 89 – San Antonio (up from No. 103 last year)
  • No. 95 – Dallas (up from No. 113 last year)
  • No. 99 – Beaumont (up from No. 131 last year)
  • No. 107 – Killeen (up from No. 122 last year)
The full report and its methodology can be found on realestate.usnews.com.

------

This article originally ran on CultureMap.

From Your Site Articles
For better or for worse, automation is going to have an affect on specific jobs in Houston. Getty Images

New report identifies the Houston jobs that are most likely going to be affected by automation

the robots are coming

A new report from UpSkill Houston, a workforce initiative of the Greater Houston Partnership, puts the implications of workplace automation into stark focus. According to the report, more than 50 percent of middle-skill jobs in the Houston area face a higher-than-average risk of being upset by automation.

Peter Beard, who leads UpSkill Houston and is senior vice president for workforce development at the Greater Houston Partnership, says this means technology will "get embedded even more in the workplace than it's ever been before. … People's jobs will change because they have to work alongside technology. And there will be some jobs that get displaced because of that technology."

"Robots are coming," he adds, "but they're not going to replace us. We're going to have to figure out how to work beside them."

Middle-skill jobs require less than a four-year bachelor's degree but more than a high school diploma. In other words, jobs fitting into this middle ground might demand a two-year associate's degree or a training certificate from a technical school.

The report, released July 16, points out that middle-skill occupations in manufacturing and construction, for instance, face a high risk of disruption as companies adopt technologies that automate tasks, such as prefabrication of building materials. By contrast, the report notes, automation places jobs in the health care and service sectors in far less jeopardy because they generally rely on tasks that can't easily be automated. For example, jobs in health care often require social skills that can't be replicated through automation, which includes artificial intelligence, robotics, and machine learning.

However, jobs in health care aren't entirely immune from shifts in the workplace. The report indicates jobs in workforce segments like health care, sales and office support, IT, management, and drafting now require a medium or high level of digital skills.

That being said, all workers — regardless of their industry, occupation, or education — must embrace solid digital skills in order to succeed in the workforce, the report states. Beard says that to compete in today's workforce, a high school graduate must be proficient in Microsoft's Word, Excel, and PowerPoint programs as well as in a customer relationship management platform like Salesforce.

The findings in the UpSkill Houston report come at a pivotal time for the Houston economy, given the job-slashing double whammy of the coronavirus pandemic and the oil slump. The pandemic "has accelerated and accentuated a fundamental change that has been underway — a change in the education and skills needed to be successful in the workforce today and into the future," the report states.

That change poses particular challenges for low-skill and middle-skill workers in the Houston area, according to the report. The report recommends that workforce development stakeholders, including employers, schools, and community organizations, build a regional "framework" aimed at ramping up skillsets so workers can seize increasingly elevated career opportunities.

"It all starts with the employer. The employer is in the best position to know what skills they need today and what skills they are likely to need tomorrow," Beard says. "Fundamentally, we're trying to create a supply chain of talent that meets the needs of our economy and the needs of our employers."

But that takes employers collaborating with schools to ensure those skills are being taught, he says, and employers and schools motivating students to consider jobs that incorporate those skills.

Beard assigns those skills to four categories:

  • Technical skills
  • Digital skills
  • Soft skills, such as communication
  • Problem-solving skills

"This whole push we've had that everyone should go to college and get a four-year degree has made folks consider jobs that don't require a four-year college degree to be menial," Beard says. "That same mentality has also permeated the employers. How many job descriptions have we seen that put a four-year degree requirement on them but that don't require four years of college education?"

New study shows Houston has more job openings than any other Texas city. Photo by Tim Leviston/Getty Images

Houston becomes job capital of Texas with highest number of openings in the state

Get to work

As all good Houstonians know, the Bayou City reigns as the energy capital of the world. But, as it turns out, Houston also ranks as the job capital of Texas.

In October, a daily average of 4,188 job openings were listed in Houston — more than any other place in Texas. That's according to a review by data-mining company Thinkum of online job postings at thousands of companies.

In terms of the sheer number of daily job postings, Houston ranked fifth among U.S. cities in October, according to Thinkum. Seattle held the No. 1 spot (10,291 average daily job listings).

Thinkum's top 20 also included Austin (No. 6), with a daily average of 3,227 job postings, and Dallas (No. 12), with 2,685.

The abundance of job listings in Houston can be attributed, in part, to its status as one of the top U.S. metro areas for corporate relocations and expansions, as ranked by Site Selection magazine. In 2017, the Houston welcomed 196 new and expanded corporate facilities.

"Houston is the most diverse city in the U.S. and companies thrive in our region. We are powered by a highly skilled and well-trained talent base that enjoys an excellent quality of life," Bob Harvey, president and CEO of the Greater Houston Partnership, said in March.

Career website LinkedIn says hiring in the Houston metro area climbed 14.3 percent in September 2018 compared with September 2017. On a seasonally adjusted basis (removing predictable variations for seasonal hiring), hiring went up 0.8 percent from August to September, according to LinkedIn.

That's good news for the Houston area, as the unemployment rate in September was 4.1 percent, according to the U.S. Bureau of Labor Statistics, compared with 3.4 percent in Dallas-Fort Worth and 2.9 percent in Austin.

A February report from Taylor Smith Consulting noted that the Houston economy had been in recovery mode after the collapse in oil prices and in the wake of Hurricane Harvey. However, one expert says Houston has now mostly bounced back from the economic slump.

Helping fuel Houston's economic recovery are initiatives like Houston Exponential, a new nonprofit designed to accelerate startup growth and, as a result, job growth. Formation of Houston Exponential was announced in October.

"The world calls Houston a knowledge capital because of the incredible concentration of ideas and innovation in our great city," Houston Mayor Sylvester Turner said in October. "Technology innovation and a vibrant startup community are key drivers to Houston's present as well as our future. Through [Houston Exponential], we will create new, high-paying jobs, grow our startup and technology community, make accessing entrepreneurship capital available to all of our citizens, improve our quality of life, and lead this culture of innovation that inspires each and every one of us."

------

This story originally appeared on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings